CHONDROPAW, LLC
OCALA, FLORIDA

Founded in May 2010, CHONDROPAW, LLC is a Florida-registered company specializing in all-natural supplements designed to support joint health in dogs. Headquartered in Ocala, Marion County with the filing number L10000049622, this company places a strong emphasis on sustainable sourcing and ethical practices, opting for bovine chondroitin instead of shark-derived variants to mitigate environmental impact and ethical concerns tied to the shark fishing industry. The flagship product, ChondroPaw®, is offered in two dispensing formats: daily or weekly administration is recommended for optimal effects when taken on an empty stomach. This premium joint supplement promises results within 30 days and encourages continued use for lasting benefits over three to six months. The company offers a 30-day satisfaction guarantee to ensure customer confidence and recommends consulting with veterinarians for any specific concerns regarding the product's use in conjunction with other medications. ChondroPaw® is acclaimed for its efficacy by customers, who note significant improvements in mobility and reduction in joint pain in their pets. It supports dogs throughout various life stages by aiding prevention, delay, stabilization, repair, or even reversal of lesions in articular cartilage and subchondral bone. The company's dedicated online platform at chondropaw.com serves as a resource for prospective customers to learn more about the benefits and usage recommendations. To maintain compliance with Florida corporate regulations, CHONDROPAW has undergone various filings, including amendments to its status reflected in documents dated May 19, 2015, and an annual report submitted on January 11, 2024. Leading CHONDROPAW are co-Managers Analissa Benedetti and Chris Mclaughlin, who guide the company's mission of improving canine joint health with responsible sourcing practices. For inquiries, clients can reach out to them at (877) 558-2789 or visit their mailing address at 5640 SW 6TH PLACE, OCALA, FL, 34474, US.